TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3434999

Group type: EXPERIMENTAL
Intervention: Home preparation with 3 liters balanced electrolyte solution (BES)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Hospital preparation with 3 liters balanced electrolyte solution (BES)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Patients unable to drink 3 liters of BES within 2 hours
Number of subjects: 62
Study: 29527927

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR) administration
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 12
Study: 27176869

Group type: EXPERIMENTAL
Intervention: LGP‐HAL (Restylane Lyft; Galderma Laboratories, L.P.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LGP‐HAL
Number of subjects: 0
Study: 24407028

Group type: EXPERIMENTAL
Intervention: Resistance exercise (R)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 17
Study: 22018755

Group type: EXPERIMENTAL
Intervention: Myofascial release technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (special attention)
Number of subjects: 20
Study: 20728636

Group type: EXPERIMENTAL
Intervention: Alcohol (BAC=0.05%)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: THC (13 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of alcohol and THC
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (drinking and smoking)
Number of subjects: 12
Study: 19001103

Group type: EXPERIMENTAL
Intervention: Online CME seminar about type 2 diabetes
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Online CME seminar about systolic heart failure
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 113
Study: 19479627

Group type: EXPERIMENTAL
Intervention: Strength training (S)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Strength-plyometric training (P)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Strength-VertiMax without arms (VNA)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Strength-VertiMax with arms (VA)
Number of subjects: 37

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 37
Study: 16113584

Group type: EXPERIMENTAL
Intervention: Intensive medical management
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine clinical care
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: E3/4 genotype
Number of subjects: 90
Study: 12195058

Group type: EXPERIMENTAL
Intervention: McKenzie method
Number of subjects: 260

Group type: COMPARATOR
Intervention: Intensive dynamic strengthening training
Number of subjects: 260
Study: 9782692

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care
Number of subjects: 231

Group type: COMPARATOR
Intervention: Traditional pharmacy care
Number of subjects: 231
Study: 8151912

Group type: EXPERIMENTAL
Intervention: S6472 capsules (375 mg, twice a day for 7 days)
Number of subjects: 199

Group type: COMPARATOR
Intervention: S6472 granules (375 mg, twice a day for 7 days)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: S6472 capsules
Number of subjects: 199

Group type: COMPARATOR
Intervention: S6472 granules
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: S6472 capsules and granules
Number of subjects: 199
Study: 3280080

Group type: EXPERIMENTAL
Intervention: Flutamide 750 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stilboestrol 3 mg daily
Number of subjects: 40
Study: 11266233

Group type: EXPERIMENTAL
Intervention: Active reflexology
Number of subjects: 40

Group type: COMPARATOR
Intervention: Simulated (placebo) reflexology
Number of subjects: 40
Study: 31597552

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 1349

Group type: EXPERIMENTAL
Intervention: Thrombus migration
Number of subjects: 1349

Group type: EXPERIMENTAL
Intervention: Thrombus migration in M1 initial target occlusion
Number of subjects: 1349

Group type: EXPERIMENTAL
Intervention: Thrombus resolution
Number of subjects: 1349
Study: 30008335

Group type: EXPERIMENTAL
Intervention: Home pedometer assisted physical activity (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Outpatient supervised exercise training program (Group 2)
Number of subjects: 40
Study: 26538427

Group type: EXPERIMENTAL
Intervention: IT + HBO treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: IV + HBO therapy
Number of subjects: 80
Study: 25376735

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (cholecalciferol) at a high dose of 100,000 UI every 2 weeks for 2 months then monthly for 22 months
Number of subjects: 640

Group type: COMPARATOR
Intervention: Vitamin D3 (cholecalciferol) at a low dose of 12,000 UI every 2 weeks for 2 months then monthly for 22 months
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: High-dose cholecalciferol (100,000 IU)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Low-dose cholecalciferol (12,000 IU)
Number of subjects: 640
Study: 22611047

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1846
Study: 20545873

Group type: EXPERIMENTAL
Intervention: Website (painACTION-Back Pain)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control (text-based material)
Number of subjects: 209
Study: 17916259

Group type: EXPERIMENTAL
Intervention: Web-based PSA decision-aid, Prosdex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (paper version of Prosdex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (questionnaire only)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 15704028

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 36
Study: 12005464

Group type: EXPERIMENTAL
Intervention: Continuous transpyloric feeding during tracheal extubation
Number of subjects: 59

Group type: COMPARATOR
Intervention: Interrupted transpyloric feeding (discontinued 4 hours before extubation and restarted 4 hours after)
Number of subjects: 59
Study: 10407712

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension 0.25 mg BID
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension 0.5 mg BID
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension 1 mg QD
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation suspension 0.25 mg QD
Number of subjects: 481

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 481
Study: 7539817

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (rhGH; 0.025 mg/kg.day)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: low dose recombinant human insulin-like growth factor-I (rhIGF-I; 0.015 mg/kg, twice daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: high dose recombinant human insulin-like growth factor-I (rhIGF-I; 0.060 mg/kg, twice daily)
Number of subjects: 16
Study: 2161626

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg 3 times a day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 81412

Group type: EXPERIMENTAL
Intervention: Hypertransfusion to a haemoglobin of 16‐‐18 g/dl (group B)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Transfusion to a haemoglobin of 10‐‐12 g/dl (group A)
Number of subjects: 26
Study: 30887178

Group type: EXPERIMENTAL
Intervention: Galunisertib + gemcitabine
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo + gemcitabine
Number of subjects: 156
Study: 29206629

Group type: EXPERIMENTAL
Intervention: Losmapimod 15 mg
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 27382274

Group type: EXPERIMENTAL
Intervention: POC PCT-guided intervention (n=62)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control arm (n=58)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 23982564

Group type: EXPERIMENTAL
Intervention: Intra-articular corticosteroid injection (IACI) of 80 mg of methylprednisolone acetate (MPA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intra-articular injection (IAI) of 6 ml (60 mg) of sodium hyaluronate (control group)
Number of subjects: 20
Study: 23427384

Group type: EXPERIMENTAL
Intervention: Lumbar tender point deep tissue massage plus lumbar traction
Number of subjects: 64

Group type: COMPARATOR
Intervention: Lumbar traction alone
Number of subjects: 64
Study: 19293690

Group type: EXPERIMENTAL
Intervention: Rotational technique (n = 80)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard technique (n = 80)
Number of subjects: 160
Study: 17219379

Group type: EXPERIMENTAL
Intervention: Intramuscular polyestradiol phosphate (PEP) 240 mg/month
Number of subjects: 444

Group type: COMPARATOR
Intervention: Orchiectomy (OE)
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Intramuscular polyestradiol phosphate (PEP)
Number of subjects: 444
Study: 15857105

Group type: EXPERIMENTAL
Intervention: 1% pimecrolimus cream applied twice daily for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 20
Study: 15094146

Group type: EXPERIMENTAL
Intervention: Underwater recording without water-resistant adhesive taping (PW)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Underwater recording with moving water and without water-resistant adhesive taping (PWM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Underwater recording with water-resistant adhesive taping (T)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dry condition (D)
Number of subjects: 10
Study: 11213071

Group type: EXPERIMENTAL
Intervention: Interferon-alpha2a, 3 mU daily for 12 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 12
Study: 9692058

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: No chemotherapy (control group)
Number of subjects: 68
Study: 7939127

Group type: EXPERIMENTAL
Intervention: Symptom diaries over a 4-month period
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 10-day diary design
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Reliability assessment
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Training period prior to trial
Number of subjects: 27

Group type: COMPARATOR
Intervention: Treatment with stimulant medications
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Daily distribution of cataplexy attacks
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Emotional events or sleepiness
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Precataplectic feeling or aura
Number of subjects: 27
Study: 2463720

Group type: EXPERIMENTAL
Intervention: Diprafenone 450 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Propafenone 450 mg/day
Number of subjects: 10
Study: 29602883

Group type: EXPERIMENTAL
Intervention: Danegaptide high dose
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Danegaptide low dose
Number of subjects: 585

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 585
Study: 28110287

Group type: EXPERIMENTAL
Intervention: Daily low-dose aspirin (100 mg)
Number of subjects: 16703

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 16703
Study: 26817346

Group type: EXPERIMENTAL
Intervention: Tocolytic drugs
Number of subjects: 499

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 499
Study: 23260616

Group type: EXPERIMENTAL
Intervention: Peer teaching in addition to faculty instruction
Number of subjects: 230

Group type: COMPARATOR
Intervention: Faculty instruction only
Number of subjects: 230
Study: 21700934

Group type: EXPERIMENTAL
Intervention: ARC1779
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 19005298

Group type: EXPERIMENTAL
Intervention: Enhanced External Counterpulsation (EECP)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Optimal Medical Treatment (Control)
Number of subjects: 153
Study: 17124449

Group type: COMPARATOR
Intervention: Intra-focal pinning (group K) using one or two dorsal pins and one lateral pin
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Trans-focal pinning (group KM) using one or two intra-focal pins and one lateral transfocal pin
Number of subjects: 85

Group type: COMPARATOR
Intervention: Intra-focal pinning (group K) at day 45 postoperative
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Trans-focal pinning (group KM) at day 45 postoperative
Number of subjects: 85
Study: 15276957

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment for neuropsychiatric symptoms of TBI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10845171

Group type: EXPERIMENTAL
Intervention: Intercede (oxidized regenerated cellulose adhesion barrier)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no adjuvant)
Number of subjects: 38
Study: 8694318

Group type: EXPERIMENTAL
Intervention: Somatosensory stimulation with 60 electric pulses (20 mA, 0.2 ms) to the tips of the fingers for 10 min, followed by continued stimulation for 20 min after anesthetic injection.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Somatosensory stimulation applied to the anesthetized finger.
Number of subjects: 10
Study: 1311661

Group type: EXPERIMENTAL
Intervention: Intralipid infusion (20% w/v, 1 ml/min for 120 min) during hyperinsulinaemic euglycaemic clamp (100 m-units h-1 kg-1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (0.154 mol/l NaCl infusion)
Number of subjects: 7
Study: 2984913

Group type: EXPERIMENTAL
Intervention: Enalapril (5 to 20 mg twice daily)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Captopril (25 to 100 mg thrice daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: ACE inhibitor placebos
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alpha-methyldopa (250 to 500 mg twice daily)
Number of subjects: 32
Study: 30471802

Group type: EXPERIMENTAL
Intervention: Strong intervention (audit, feedback, collaborative work with a hospital geriatrician)
Number of subjects: 3722

Group type: COMPARATOR
Intervention: Light intervention group (audit and feedback only)
Number of subjects: 3722

Group type: EXPERIMENTAL
Intervention: Strong intervention
Number of subjects: 3722
Study: 26786577

Group type: EXPERIMENTAL
Intervention: CANA100/MET
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: CANA300/MET
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: CANA100
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: CANA300
Number of subjects: 1186

Group type: COMPARATOR
Intervention: MET
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: CANA arms
Number of subjects: 1186
Study: 24119443

Group type: EXPERIMENTAL
Intervention: 5-FU/oxaliplatin chemotherapy
Number of subjects: 150
Study: 21828031

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg every 6 h until neutropenia)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Historical controls (1994‐2002)
Number of subjects: 20
Study: 19484628

Group type: EXPERIMENTAL
Intervention: Rivastigmine (Exelon) at a maximum dose of 12 mg daily for 8 weeks
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 17252021

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM‐CSF)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control (timed‐sequential induction regimen alone)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Control (timed‐sequential consolidation without GM‐CSF)
Number of subjects: 259
Study: 15684231

Group type: EXPERIMENTAL
Intervention: Hypericum extracts (St John's wort)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Standard antidepressants
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 12230056

Group type: EXPERIMENTAL
Intervention: Minimal access surgery (MAS)
Number of subjects: 2195

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 2195
Study: 10086836

Group type: EXPERIMENTAL
Intervention: 50 mg dose of dolasetron mesylate solution
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 100 mg dose of dolasetron mesylate solution
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 200 mg dose of dolasetron mesylate solution
Number of subjects: 18
Study: 7733082

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg p.o. b.i.d. for 1 week
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo for 1 week
Number of subjects: 9
Study: 1647194

Group type: EXPERIMENTAL
Intervention: Granisetron 160 micrograms kg-1
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 6122327

Group type: EXPERIMENTAL
Intervention: Lorazepam (0.05 mg/kg)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Pethidine (1 mg/kg)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Oxycodone (0.14 mg/kg)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Light premedication
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Amnesic premedication
Number of subjects: 130

Group type: COMPARATOR
Intervention: Amnesic premedication (received by patients expecting light premedication)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Light premedication (received by patients expecting amnesic premedication)
Number of subjects: 130
Study: 6368765

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (Vancomycin and Gentamicin administered systemically, Streptomycin in irrigating solution)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no prophylactic antibiotics)
Number of subjects: 0
Study: 30544795

Group type: EXPERIMENTAL
Intervention: Spirulina maxima (4.5 g for 12 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 27804270

Group type: EXPERIMENTAL
Intervention: Memory training
Number of subjects: 2684

Group type: EXPERIMENTAL
Intervention: Reasoning training
Number of subjects: 2684

Group type: EXPERIMENTAL
Intervention: Speed of processing training
Number of subjects: 2684

Group type: COMPARATOR
Intervention: No-training control group
Number of subjects: 2684
Study: 25198224

Group type: COMPARATOR
Intervention: Floor exercises
Number of subjects: 39

Group type: COMPARATOR
Intervention: High Magnitude Mechanical Stimulation (HMMS)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: HMMS
Number of subjects: 39

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 39
Study: 22436536

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT) administration
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 20381660

Group type: EXPERIMENTAL
Intervention: Current use of NSAIDs
Number of subjects: 2954

Group type: EXPERIMENTAL
Intervention: High doses of NSAIDs
Number of subjects: 2954

Group type: EXPERIMENTAL
Intervention: NSAIDs in patients with previous ischemic heart disease
Number of subjects: 2954
Study: 19010617

Group type: EXPERIMENTAL
Intervention: Estradiol 2mg/day (ERT)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Estradiol 2mg/day plus medroxyprogesterone acetate 5mg/day (HRT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 15831684

Group type: EXPERIMENTAL
Intervention: Consumption of at least one folate fortified food
Number of subjects: 468

Group type: COMPARATOR
Intervention: Subjects who consumed at least one folate fortified food
Number of subjects: 468
Study: 12167942

Group type: EXPERIMENTAL
Intervention: Active sodium bicarbonate oral composition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 9012623

Group type: EXPERIMENTAL
Intervention: Albuterol 100 micrograms via Turbuhaler (2 x 50 micrograms)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Albuterol 200 micrograms via pMDI (2 x 100 micrograms)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Albuterol 100 micrograms via Turbuhaler
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 37
Study: 7881024

Group type: EXPERIMENTAL
Intervention: Intravenous human epidermal growth factor (hEGF) 6 micrograms twice a week
Number of subjects: 173

Group type: COMPARATOR
Intervention: Cetraxate hydrochloride (CH)
Number of subjects: 173
Study: 3203698

Group type: EXPERIMENTAL
Intervention: Increased daily fluid intake (1.51 liters per day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard daily fluid intake (3.01 liters per day)
Number of subjects: 100
Study: 31844950

Group type: EXPERIMENTAL
Intervention: Intra-articular steroid with hydrodilatation (distension group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Only intra-articular steroid (non-distension group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intra-articular steroid with hydrodilatation (distension group) among diabetics
Number of subjects: 40

Group type: COMPARATOR
Intervention: Only intra-articular steroid (non-distension group) among diabetics
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intra-articular steroid with hydrodilatation (distension group) among diabetic and non-diabetic patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Only intra-articular steroid (non-distension group) among diabetic and non-diabetic patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 29650210

Group type: EXPERIMENTAL
Intervention: Chair yoga with spiritual intervention
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study: 26391390

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT) with orally administered estrogen and medroxyprogesterone acetate
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 88
Study: 24684774

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 22928654

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (1x108 cfu)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 20920040

Group type: EXPERIMENTAL
Intervention: Phentermine DCR 30 mg
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 18040272

Group type: EXPERIMENTAL
Intervention: Panitumumab
Number of subjects: 391

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: No progressive disease (no PD) patients
Number of subjects: 391

Group type: COMPARATOR
Intervention: Progressive disease (PD) patients
Number of subjects: 391